| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.19 | 9e-05 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |